171. Nat Commun. 2018 Jul 4;9(1):2601. doi: 10.1038/s41467-018-04900-7.Systematic discovery of germline cancer predisposition genes through theidentification of somatic second hits.Park S(1), Supek F(1)(2)(3)(2), Lehner B(4)(5)(6).Author information: (1)Systems Biology Program, Centre for Genomic Regulation (CRG), The BarcelonaInstitute of Science and Technology, Dr Aiguader 88, 08003, Barcelona, Spain.(2)Institut de Recerca Biomedica (IRB Barcelona), The Barcelona Institute ofScience and Technology, 08028, Barcelona, Spain.(3)Division of Electronics, Rudjer Boskovic Institute, 10000, Zagreb, Croatia.(4)Systems Biology Program, Centre for Genomic Regulation (CRG), The BarcelonaInstitute of Science and Technology, Dr Aiguader 88, 08003, Barcelona, Spain.ben.lehner@crg.eu.(5)Universitat Pompeu Fabra (UPF), 08003, Barcelona, Spain. ben.lehner@crg.eu.(6)Institució Catalana de Recerca i Estudis Avançats (ICREA), Pg. Luis Companys23, 08010, Barcelona, Spain. ben.lehner@crg.eu.The genetic causes of cancer include both somatic mutations and inheritedgermline variants. Large-scale tumor sequencing has revolutionized theidentification of somatic driver alterations but has had limited impact on theidentification of cancer predisposition genes (CPGs). Here we present astatistical method, ALFRED, that tests Knudson's two-hit hypothesis tosystematically identify CPGs from cancer genome data. Applied to ~10,000 tumorexomes the approach identifies known and putative CPGs - including the chromatin modifier NSD1 - that contribute to cancer through a combination of rare germline variants and somatic loss-of-heterozygosity (LOH). Rare germline variants inthese genes contribute substantially to cancer risk, including to ~14% of ovariancarcinomas, ~7% of breast tumors, ~4% of uterine corpus endometrial carcinomas,and to a median of 2% of tumors across 17 cancer types.DOI: 10.1038/s41467-018-04900-7 PMCID: PMC6031629PMID: 29973584 